Skip to main content
. 2022 Jul 14;2022:2960773. doi: 10.1155/2022/2960773

Figure 1.

Figure 1

miR-760 level and prognosis in NSCLC patients. (a) The miR-760 level in NSCLC patients is tested via qRT-PCR. (b) The miR-760 level in different stages of NSCLC patients is tested via qRT-PCR. (c) The total survival of patients in miR-760 high and low expression groups is assessed via K-M survival. (d) The miR-760 level in LC cell lines is tested via qRT-PCR. P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.